26094-13-3

Basic information

• Product Name: N-BUTYLAMINE OLEATE
• Synonyms: butylamineoleate;compd.with1-butanamine(1:1);oleicacid,compd.withbutylamine(1:1);N-BUTYLAMINE OLEATE;butylammonium oleate
• CAS NO: 26094-13-3
• Molecular Formula: C₄H₁₁N*C₁₈H₃₄O₂
• Molecular Weight: 355.6
• EINECS: 247-456-9
• Mol File: 26094-13-3.mol

Chemical Properties

• Boiling Point: 456.8°Cat760mmHg
• Flash Point: 230.1°C
• Appearance: /
• Density: g/cm³
• Vapor Pressure: 1.29E-09mmHg at 25°C
• CAS DataBase Reference: N-BUTYLAMINE OLEATE(CAS DataBase Reference)
• NIST Chemistry Reference: N-BUTYLAMINE OLEATE(26094-13-3)
• EPA Substance Registry System: N-BUTYLAMINE OLEATE(26094-13-3)

Safety Data

• Hazardous Substances Data: 26094-13-3(Hazardous Substances Data)

Usage

Safety Profile

A skin and eye irritant. Whenheated to decomposition it emits toxic vapors of NOx.

InChI:InChI=1/C18H34O2.C4H11N/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20;1-2-3-4-5/h9-10H,2-8,11-17H2,1H3,(H,19,20);2-5H2,1H3/b10-9+;

Upstream product

• 112-80-1 cis-Octadecenoic acid 
• 109-73-9 N-butylamine 

Relevant articles and documents

Synthesis and characterization of new low-cost ILs based on butylammonium cation and application to lignocellulose hydrolysis

Fourteen ionic liquids (ILs) were obtained and characterized by nuclear magnetic resonance and infra-red spectroscopy. One of these liquids, n-butylammonium acetate, was used in the treatment of coir fiber prior to acid hydrolysis. For this purpose, the fiber was pulped with 8% (w/w) sodium hydroxide for 6 h under 2.5 atm pressure at 137 °C and then treated with IL for 2 h at 90 °C. The samples were hydrolyzed in acetic acid at different concentrations and temperatures. The reducing sugar concentrations were determined in all samples, and the optimal hydrolysis conditions were established (32.2% acetic acid at 122.4 °C). The reaction time was also studied, and the conversion was maximized at 3 h. Under the best hydrolysis conditions, crude fiber, pulping fiber, and IL-treated fiber were hydrolyzed to yield 8.53%, 47.58%, and 89.75% of reducing sugars, respectively.

Drug specific, tuning of an ionic liquid's hydrophilic-lipophilic balance to improve water solubility of poorly soluble active pharmaceutical ingredients

Amphotericin B and itraconazole were used to demonstrate that ionic liquids can be designed or chosen to provide tunable hydrophilicity in one ion and lipophilicity in the other allowing one to match the structural requirements needed to solubilize poorly water soluble active pharmaceutical ingredients. These liquid, amphiphilic excipients could be used as both drug delivery systems and solubilization agents to improve the aqueous solubility of many drugs. The solubility in deionized water, simulated gastric fluid, simulated intestinal fluid, and phosphate buffer solution was greatly improved over current methods for drug delivery by utilizing designed ionic liquids as excipients.